Nomura Asset Management International’s Day One Biopharmaceuticals DAWN Stock Holding History

Nomura Asset Management International’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-110,000	Closed	-$2.36M	–	1363
2026 Q1	$2.36M	Hold	110,000	–	–	﹤0.01%	940
2025 Q4	$1.02M	Buy	+110,000	New	+$919K	﹤0.01%	1094

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nomura Asset Management International's DAWN Position: Q2 2026 in Review

Nomura Asset Management International sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 110,000 shares — an estimated $2.36M sold.

Nomura Asset Management International first reported a position in DAWN in Q4 2025 and held it in 2 quarters. The position peaked at $2.36M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Nomura Asset Management International reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Nomura Asset Management International sold 110,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.36M.
Nomura Asset Management International first reported a position in Day One Biopharmaceuticals in Q4 2025 and held it in 2 quarters.
Nomura Asset Management International's Day One Biopharmaceuticals position peaked at $2.36M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.